These findings demonstrate that in this SCA2 model, increased responsiveness of SCA2 PNs to mGluR1 activation mirrors the progressive appearance of biochemical, physiological, and behavioral signs of pathology (Hansen et al., 2013). The gene discussed is GRM1; the disease is spinocerebellar ataxia type 2.